Provided by Tiger Fintech (Singapore) Pte. Ltd.

TELA Bio, Inc.

2.35
-0.0800-3.29%
Post-market: 2.350.00000.00%16:05 EDT
Volume:92.86K
Turnover:219.35K
Market Cap:92.56M
PE:-1.39
High:2.45
Open:2.43
Low:2.33
Close:2.43
Loading ...

TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
28 Feb

BRIEF-Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
22 Feb

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
22 Feb

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
25 Jan

Retail investors account for 41% of TELA Bio, Inc.'s (NASDAQ:TELA) ownership, while institutions account for 28%

Simply Wall St.
·
12 Jan

Lake Street Keeps Their Buy Rating on TELA Bio (TELA)

TIPRANKS
·
07 Jan

BRIEF-Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
14 Dec 2024

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
14 Dec 2024

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
14 Dec 2024

The past five years for TELA Bio (NASDAQ:TELA) investors has not been profitable

Simply Wall St.
·
01 Dec 2024

TELA Bio Set for Growth with Strategic Enhancements and Financial Improvements

TIPRANKS
·
22 Nov 2024

TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference

GlobeNewswire
·
20 Nov 2024

TELA Bio’s Strong Financial Performance and Strategic Positioning Justify Buy Rating

TIPRANKS
·
13 Nov 2024

TELA Bio Third Quarter 2024 Earnings: EPS Beats Expectations

Simply Wall St.
·
10 Nov 2024

Even With A 27% Surge, Cautious Investors Are Not Rewarding TELA Bio, Inc.'s (NASDAQ:TELA) Performance Completely

Simply Wall St.
·
09 Nov 2024

TELA Bio Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
09 Nov 2024